Bristol Myers Squibb said on Wednesday it is partnering with Anthropic to make ​its Claude AI model available to ‌over 30,000 employees in an effort to accelerate the discovery, development and delivery of new medicines.

Follow the biggest business stories of the day with Reuters. Subscribe for $1/week. Subscribe now.

 

Reuters Business

Reuters Business

 

Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery 

 

Chipmaker Analog Devices forecasts third-quarter revenue above estimates amid AI boom 

 

Fears of unfettered hacking spurred by Anthropic's Mythos AI model overstated 

 

Target doubles annual sales growth forecast as turnaround starts to pay off 

 

Lowe's sticks to forecasts as US housing pressure persists 

 

Morning Bid: Nvidia vigil 

 

Hasbro beats quarterly estimates on strong demand for its digital games 

 

AI financing fueling a surge in U.S. convertible bond sales  

 

Samsung union says to embark on 48,000-strong strike on Thursday after impasse on bonuses 

 

Meta offers AI rival chatbots limited free WhatsApp access, sources say 

 

Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website

LiveIntent Logo
AdChoices Logo
 

Reuters Business is sent every weekday. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.

Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here.

This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement.

Terms & Conditions

 

© 2026 Thomson Reuters. All rights reserved.
3 Times Square, New York, NY 10036